statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pathos AI, Inc. (Pathos) today announced that it has, through its wholly owned subsidiary WK Merger Sub, Inc. (Merger Sub), successfully completed its tender offer to acquire all outstanding shares...

Pathos AI Completes Acquisition of Rain Oncology

NEW YORK, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FGH, RAIN, PGTI, AYX

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICVX, DSKE, RAIN, CNSL SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICVX, DSKE, RAIN, CNSL PR Newswire NEW YORK, Jan. 4, 2024 NEW...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICVX, DSKE, RAIN, CNSL

Kuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to Contact Law Firm Kuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to Contact Law Firm PR Newswire NEW YORK, Jan. 3, 2024 NEW YORK...

Kuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to Contact Law Firm

NEW YORK, Jan. 01, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICVX, CVLY, RAIN, X

Rain Oncology is a clinical-stage company focusing on research and development of innovative therapies for cancer patients.  Rain Oncology provides a tumor-agnostic strategy to select patients based on tumorsâ?? underlying genetics rather than histology.  Rain Oncology was founded in 2017 and was headquartered in Newark, California.

Rain Oncology Inc

Rain Therapeutics Inc

Watchers	1,002
52-Wk Low	$0.82
52-Wk High	$11.32

Volume	3.71M
52-Wk High	$11.32
52-Wk Low	$0.82

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.34	--	--	N/A
Q4'23	-$0.29	--	--	N/A
Q3'23	-$0.28	-$0.19	31.13%	BEAT
Q2'23	-$0.51	-$0.61	-20.62%	MISSED
Q1'23	-$0.62	-$0.56	9.00%	BEAT

RAIN Rain Therapeutics Inc

About

Feed

News

Earnings

Fundamentals